STW:PA:PA-SPDR® MSCI Europe Health Care UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 228.65

Change

-2.00 (-0.87)%

Market Cap

USD 0.79B

Volume

108.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.31 (+0.66%)

USD 64.41B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.40 (-0.08%)

USD 12.63B
WRD:PA HSBC ETFs Public Limited Compa..

-0.10 (-0.30%)

USD 10.26B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-2.10 (-0.86%)

USD 8.94B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

N/A

USD 7.98B
HHH:PA HSBC ETFs Public Limited Compa..

-0.05 (-0.09%)

USD 7.03B
WLD:PA Lyxor UCITS MSCI World D-EUR

-0.75 (-0.22%)

USD 6.87B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.06 (-0.35%)

USD 6.47B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

N/A

USD 5.17B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.30 (+0.20%)

USD 4.78B

ETFs Containing STW:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.90% 65% D 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.90% 67% D+ 73% C
Trailing 12 Months  
Capital Gain 14.54% 34% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.54% 32% F 58% F
Trailing 5 Years  
Capital Gain 58.98% 68% D+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 58.98% 67% D+ 72% C
Average Annual (5 Year Horizon)  
Capital Gain 8.57% N/A N/A 61% D-
Dividend Return 8.57% N/A N/A 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.35% N/A N/A 85% B
Risk Adjusted Return 102.63% N/A N/A 96% N/A
Market Capitalization 0.79B 78% C+ 78% C+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike